Premium
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-21 | Mr. Kevin HettrichCFO | -9,80k | 78,98k | Automatic Disposition | 8,06 | 477,47k | -2,01% |
| 2026-05-21 | Dr. Timothy HolmeCo-Founder & CTO | -118,42k | 974,86k | Derivative Exercise and Sale | 8,23 | 129,83k | - |
| 2026-05-18 | Dr. Timothy HolmeCo-Founder & CTO | -31,32k | 230,91k | Sale to Issuer | 7,37 | 129,83k | -19,44% |
| 2026-05-20 | Dr. Timothy HolmeCo-Founder & CTO | -23,11k | 173,35k | Automatic Disposition | 7,50 | 129,83k | -15,11% |
| 2026-05-20 | Dr. Timothy HolmeCo-Founder & CTO | -161,33k | 1,21M | Derivative Exercise and Sale | 7,50 | 129,83k | - |
| 2026-05-18 | Dr. Srinivasan SivaramPresident, CEO & Director | -67,37k | 496,65k | Sale to Issuer | 7,37 | 1,07M | -5,94% |
| 2026-05-18 | Dr. Luca FasoliCOO | -108,07k | 796,67k | Sale to Issuer | 7,37 | 166,66k | -39,34% |
| 2026-05-18 | Dr. Mohit SinghChief Development Officer | -31,91k | 233,64k | Sale to Issuer | 7,32 | 1,77M | -1,77% |
| 2026-05-18 | Mr. Kevin HettrichCFO | -30,54k | 225,11k | Sale to Issuer | 7,37 | 487,27k | -5,90% |
| 2026-05-18 | Mr. Michael O. McCarthyChief Legal Officer & Head of Corporate Development | -24,21k | 178,49k | Sale to Issuer | 7,37 | 255,88k | -8,64% |
| 2026-05-12 | Mr. Jeffrey Brian StraubelIndependent Director | -27,11k | 212,87k | Automatic Disposition | 7,85 | 83,11k | -24,59% |
| 2026-05-06 | Dr. Mohit SinghChief Development Officer | -50,00k | 393,71k | Vente | 7,87 | 201,54k | -19,88% |
| 2026-04-30 | Dr. Srinivasan SivaramPresident, CEO & Director | -212,08k | 0,00 | Other Disposition | - | 1,02M | -17,25% |
| 2026-04-02 | Mr. Kevin HettrichCFO | -9,80k | 60,80k | Automatic Disposition | 6,20 | 464,74k | -2,07% |
| 2026-04-02 | Mr. Jeffrey Brian StraubelIndependent Director | -27,11k | 167,21k | Automatic Disposition | 6,17 | 110,21k | -19,74% |
| 2026-04-02 | Dr. Timothy HolmeCo-Founder & CTO | -161,33k | 996,62k | Derivative Exercise and Sale | 6,18 | 129,83k | - |
| 2026-03-11 | Mr. Jeffrey Brian StraubelIndependent Director | -27,11k | 188,38k | Vente | 6,95 | 137,32k | -16,49% |
| 2026-03-11 | Mr. Kevin HettrichCFO | -9,80k | 68,13k | Vente | 6,95 | 474,54k | -2,02% |
| 2026-03-04 | Mr. Michael O. McCarthyChief Legal Officer & Head of Corporate Development | -75,00k | 510,00k | Vente | 6,73 - 6,90 | 229,29k | -24,65% |
| 2026-03-05 | Dr. Timothy HolmeCo-Founder & CTO | -161,33k | 1,11M | Derivative Exercise and Sale | 6,86 | 129,83k | - |
| 2026-02-25 | Mr. Michael O. McCarthyChief Legal Officer & Head of Corporate Development | -18,39k | 129,65k | Sale to Issuer | 7,05 | 304,29k | -5,70% |
| 2026-02-25 | Dr. Srinivasan SivaramPresident, CEO & Director | -77,14k | 543,77k | Sale to Issuer | 7,05 | 1,23M | -5,91% |
| 2026-02-25 | Dr. Luca FasoliCOO | -13,96k | 98,42k | Sale to Issuer | 7,05 | 86,90k | -13,84% |
| 2026-02-25 | Dr. Timothy HolmeCo-Founder & CTO | -22,37k | 157,66k | Sale to Issuer | 7,05 | 129,83k | -14,70% |
| 2026-02-25 | Dr. Mohit SinghChief Development Officer | -22,79k | 160,64k | Sale to Issuer | 7,05 | 251,54k | -8,31% |
| 2026-02-23 | Mr. Kevin HettrichCFO | -9,80k | 66,21k | Automatic Disposition | 6,76 | 484,34k | -1,98% |
| 2026-02-25 | Mr. Kevin HettrichCFO | -21,79k | 153,59k | Sale to Issuer | 7,05 | 484,34k | -4,31% |
| 2026-02-18 | Mr. Michael O. McCarthyChief Legal Officer & Head of Corporate Development | -76,69k | 546,64k | Sale to Issuer | 7,08 - 7,14 | 280,65k | -21,46% |
| 2026-02-18 | Dr. Luca FasoliCOO | -87,48k | 624,97k | Sale to Issuer | 7,14 | 74,44k | -54,03% |
| 2026-02-18 | Dr. Srinivasan SivaramPresident, CEO & Director | -283,81k | 2,03M | Sale to Issuer | 7,08 - 7,14 | 1,16M | -19,65% |
| 2026-02-18 | Dr. Mohit SinghChief Development Officer | -131,45k | 937,52k | Sale to Issuer | 7,08 - 7,14 | 232,01k | -36,17% |
| 2026-02-19 | Dr. Timothy HolmeCo-Founder & CTO | -161,33k | 1,15M | Derivative Exercise and Sale | 7,10 | 109,88k | - |
| 2026-02-20 | Dr. Timothy HolmeCo-Founder & CTO | -34,12k | 237,72k | Automatic Disposition | 6,97 | 109,88k | -23,69% |
| 2026-02-18 | Dr. Timothy HolmeCo-Founder & CTO | -129,04k | 920,29k | Sale to Issuer | 7,08 - 7,14 | 109,88k | -54,01% |
| 2026-02-18 | Mr. Kevin HettrichCFO | -117,26k | 836,19k | Sale to Issuer | 7,08 - 7,14 | 474,70k | -19,81% |
| 2026-02-19 | Mr. Jeffrey Brian StraubelIndependent Director | -27,11k | 192,46k | Automatic Disposition | 7,10 | 164,42k | -14,15% |
| 2026-01-14 | Mr. Kevin HettrichCFO | -9,80k | 103,79k | Automatic Disposition | 10,59 | 374,43k | -2,55% |
| 2026-01-05 | Mr. Jeffrey Brian StraubelIndependent Director | -27,11k | 305,69k | Automatic Disposition | 11,28 | 191,53k | -12,40% |
| 2026-01-05 | Dr. Timothy HolmeCo-Founder & CTO | -211,36k | 2,38M | Derivative Exercise and Sale | 11,28 | 33,52k | - |
| 2025-12-19 | Mr. Jeffrey Brian StraubelIndependent Director | -130,07k | 1,17M | Derivative Exercise and Sale | 2,38 - 11,38 | 218,64k | - |
| 2025-12-19 | Mr. Jeffrey Brian StraubelIndependent Director | -27,11k | 308,53k | Automatic Disposition | 11,38 | 218,64k | -11,03% |
| 2025-12-15 | Mr. Kevin HettrichCFO | -9,80k | 108,53k | Automatic Disposition | 11,07 | 381,73k | -2,50% |
| 2025-12-15 | Dr. Gena C. LovettIndependent Director | -3,40k | 0,00 | Other Disposition | - | 71,98k | -4,51% |
| 2025-12-12 | Capricorn Investment Group LLCSociété | -3,30M | 36,94M | Vente | 11,01 - 11,94 | 9,89M | -25,00% |
| 2025-12-04 | Dr. Timothy HolmeCo-Founder & CTO | -211,36k | 2,68M | Derivative Exercise and Sale | 12,69 | 33,52k | - |
| 2025-11-24 | Mr. Michael O. McCarthyChief Legal Officer & Head of Corporate Development | -76,42k | 894,18k | Vente | 11,60 - 11,79 | 137,89k | -35,66% |
| 2025-11-24 | Mr. Michael O. McCarthyChief Legal Officer & Head of Corporate Development | -76,42k | 0,00 | Other Disposition | - | 137,89k | -35,66% |
| 2025-11-21 | Mr. Kevin HettrichCFO | -9,80k | 110,67k | Automatic Disposition | 11,28 - 11,65 | 391,53k | -2,44% |
| 2025-11-18 | Mr. Michael O. McCarthyChief Legal Officer & Head of Corporate Development | -59,87k | 781,07k | Sale to Issuer | 13,04 - 13,46 | 214,30k | -21,84% |
| 2025-11-18 | Dr. Srinivasan SivaramPresident, CEO & Director | -258,68k | 3,37M | Sale to Issuer | 13,04 - 13,46 | 914,76k | -22,04% |
| 2025-11-18 | Dr. Mohit SinghChief Development Officer | -79,01k | 1,03M | Sale to Issuer | 13,04 - 13,46 | 123,18k | -39,08% |
| 2025-11-18 | Mr. Kevin HettrichCFO | -79,43k | 1,04M | Sale to Issuer | 13,04 - 13,46 | 401,33k | -16,52% |
| 2025-11-19 | Dr. Timothy HolmeCo-Founder & CTO | -211,36k | 2,64M | Derivative Exercise and Sale | 12,51 | 33,52k | - |
| 2025-11-19 | Dr. Timothy HolmeCo-Founder & CTO | -35,34k | 442,17k | Automatic Disposition | 12,51 | 33,52k | -51,33% |
| 2025-11-18 | Dr. Timothy HolmeCo-Founder & CTO | -77,55k | 1,01M | Sale to Issuer | 13,04 - 13,46 | 33,52k | -69,82% |
| 2025-11-07 | Mr. Michael O. McCarthyChief Legal Officer & Head of Corporate Development | -20,44k | 329,44k | Vente | 16,12 | 137,89k | -12,91% |
| 2025-11-07 | Mr. Michael O. McCarthyChief Legal Officer & Head of Corporate Development | -158,32k | 0,00 | Other Disposition | - | 137,89k | -53,45% |
| 2025-11-05 | Mr. Jeffrey Brian StraubelIndependent Director | -130,07k | 1,88M | Derivative Exercise and Sale | 2,38 - 17,03 | 245,74k | - |
| 2025-11-05 | Mr. Jeffrey Brian StraubelIndependent Director | -27,11k | 472,55k | Automatic Disposition | 17,03 - 17,61 | 245,74k | -9,93% |
| 2025-10-31 | Mr. Bradley W. BussIndependent Director | -300,00k | 3,52M | Derivative Exercise and Sale | 6,23 - 18,41 | 394,00k | - |
| 2025-10-30 | Mr. Michael O. McCarthyChief Legal Officer & Head of Corporate Development | -50,00k | 670,14k | Derivative Exercise and Sale | 2,38 - 15,78 | 158,32k | - |
| 2025-10-24 | Mr. Michael O. McCarthyChief Legal Officer & Head of Corporate Development | -25,00k | 322,10k | Derivative Exercise and Sale | 2,38 - 15,26 | 158,32k | - |
| 2025-10-24 | Mr. Michael O. McCarthyChief Legal Officer & Head of Corporate Development | -21,26k | 324,51k | Vente | 15,26 | 158,32k | -11,84% |
| 2025-10-24 | Mr. Bradley W. BussIndependent Director | -400,00k | 3,81M | Derivative Exercise and Sale | 6,23 - 16,44 | 394,00k | - |
| 2025-10-24 | Dr. Mohit SinghChief Development Officer | -62,98k | 800,33k | Derivative Exercise and Sale | 2,38 - 15,09 | 55,78k | - |
| 2025-10-24 | Dr. Mohit SinghChief Development Officer | -157,03k | 2,37M | Vente | 15,09 | 55,78k | -73,79% |
| 2025-10-24 | Prof. Friedrich PrinzInitié | -980,88k | 15,19M | Derivative Exercise and Sale | 15,47 - 15,98 | 0,00 | - |
| 2025-10-24 | Prof. Friedrich PrinzInitié | -19,12k | 300,87k | Vente | 15,47 - 15,98 | 0,00 | -100,00% |
| 2025-10-24 | Dr. Srinivasan SivaramPresident, CEO & Director | -120,00k | 2,03M | Vente | 16,61 - 17,05 | 690,27k | -14,81% |
| 2025-10-03 | Dr. Timothy HolmeCo-Founder & CTO | -153,58k | 2,38M | Derivative Exercise and Sale | 15,52 | 0,00 | - |
| 2025-10-03 | Dr. Timothy HolmeCo-Founder & CTO | -57,79k | 896,77k | Automatic Disposition | 15,52 | 0,00 | -100,00% |
| 2025-10-01 | Mr. Kevin HettrichCFO | -9,80k | 136,64k | Automatic Disposition | 13,94 | 330,93k | -2,88% |
| 2025-10-01 | Mr. Jeffrey Brian StraubelIndependent Director | -130,07k | 1,50M | Derivative Exercise and Sale | 2,38 - 13,94 | 272,85k | - |
| 2025-10-01 | Mr. Jeffrey Brian StraubelIndependent Director | -27,11k | 377,78k | Automatic Disposition | 13,94 | 272,85k | -9,04% |
| 2025-09-12 | Mr. Kevin HettrichCFO | -9,80k | 90,18k | Automatic Disposition | 9,20 | 340,73k | -2,80% |
| 2025-09-12 | Mr. Michael O. McCarthyChief Legal Officer & Head of Corporate Development | -38,04k | 347,27k | Vente | 9,13 | 179,59k | -17,48% |
| 2025-09-12 | Mr. Jeffrey Brian StraubelIndependent Director | -130,07k | 887,41k | Derivative Exercise and Sale | 2,38 - 9,20 | 299,95k | - |
| 2025-09-12 | Mr. Jeffrey Brian StraubelIndependent Director | -27,11k | 249,43k | Automatic Disposition | 9,20 | 299,95k | -8,29% |
| 2025-09-04 | Dr. Timothy HolmeCo-Founder & CTO | -44,92k | 352,33k | Derivative Exercise and Sale | 7,55 - 9,63 | 57,79k | - |
| 2025-09-04 | Dr. Timothy HolmeCo-Founder & CTO | -199,60k | 1,55M | Automatic Disposition | 7,55 - 9,63 | 57,79k | -77,55% |
| 2025-08-19 | Dr. Mohit SinghChief Development Officer | -23,60k | 204,17k | Automatic Disposition | 8,65 | 212,81k | -9,98% |
| 2025-08-18 | Dr. Mohit SinghChief Development Officer | -41,03k | 357,09k | Sale to Issuer | 8,70 | 212,81k | -16,17% |
| 2025-08-18 | Mr. Michael O. McCarthyChief Legal Officer & Head of Corporate Development | -31,77k | 276,44k | Sale to Issuer | 8,70 | 217,62k | -12,74% |
| 2025-08-18 | Mr. Kevin HettrichCFO | -39,52k | 343,93k | Sale to Issuer | 8,70 | 350,53k | -10,13% |
| 2025-08-18 | Dr. Timothy HolmeCo-Founder & CTO | -40,27k | 350,46k | Sale to Issuer | 8,70 | 257,38k | -13,53% |
| 2025-08-18 | Dr. Srinivasan SivaramPresident, CEO & Director | -84,52k | 735,56k | Sale to Issuer | 8,70 | 810,27k | -9,45% |
| 2025-07-25 | Mr. Michael O. McCarthyChief Legal Officer & Head of Corporate Development | -300,00k | 2,77M | Derivative Exercise and Sale | 2,38 - 11,60 | 179,59k | - |
| 2025-07-25 | Mr. Michael O. McCarthyChief Legal Officer & Head of Corporate Development | -200,00k | 2,32M | Vente | 11,60 | 179,59k | -52,69% |
| 2025-07-25 | Prof. Friedrich PrinzInitié | -498,01k | 5,79M | Derivative Exercise and Sale | 11,62 | 0,00 | - |
| 2025-07-25 | Prof. Friedrich PrinzInitié | -501,99k | 5,83M | Vente | 11,62 | 0,00 | -100,00% |
| 2025-07-16 | Dr. Srinivasan SivaramPresident, CEO & Director | -450,00k | 0,00 | Other Disposition | - | 740,67k | -37,79% |
| 2025-07-08 | Dr. Mohit SinghChief Development Officer | -465,00k | 2,88M | Derivative Exercise and Sale | 1,33 - 8,21 | 204,01k | - |
| 2025-07-03 | Dr. Timothy HolmeCo-Founder & CTO | -355,98k | 2,24M | Derivative Exercise and Sale | 1,33 - 7,03 | 224,23k | - |
| 2025-07-03 | Dr. Timothy HolmeCo-Founder & CTO | -155,83k | 1,09M | Automatic Disposition | 7,02 - 7,03 | 224,23k | -41,00% |
| 2025-07-03 | Prof. Friedrich PrinzInitié | -864,71k | 6,07M | Automatic Disposition | 7,02 | 501,99k | -63,27% |
| 2025-06-25 | Dr. Mohit SinghChief Development Officer | -615,00k | 3,01M | Derivative Exercise and Sale | 1,33 - 7,21 | 204,01k | - |
| 2025-06-04 | Dr. Jurgen LeoholdInitié | -10,27k | 42,25k | Sale to Issuer | 4,11 | 150,21k | -6,40% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
